Subject: RE: ***New WHO Interim Guidance on COVID-19 Clinical Management***
From: Tamar Gabunia </O=EXCHORGANIZATION/OU=EXCHANGE ADMINISTRATIVE GROUP (FYDIBOHF23SPDLT)/CN=RECIPIENTS/CN=E6CA04F38EC94D0CADAB9CBDF90FCDDE-TAMAR G>
To: Alisa Tsuladze </o=ExchOrganization/ou=Exchange Administrative Group (FYDIBOHF23SPDLT)/cn=Recipients/cn=6c6cfa06d9a74264a5aa512b6bc62306-Alisa T>
Cc: Anzor tchavtchavadze </o=ExchOrganization/ou=Exchange Administrative Group (FYDIBOHF23SPDLT)/cn=Recipients/cn=0e03f3df18104f3b8b06b0400c558fbf-Anzor t>; Ekaterine Adamia </o=ExchOrganization/ou=Exchange Administrative Group (FYDIBOHF23SPDLT)/cn=Recipients/cn=89b4d31758d34f2cbdcfe688199f6941-Ekateri>
Date: Mon, 25 May 2020 10:36:44 +0000

მადლობა ალისა!

From: Alisa Tsuladze
Sent: 25 May, 2020 14:01
To: Tamar Gabunia <[email-masked]>
Cc: Anzor tchavtchavadze <[email-masked]>; Ekaterine Adamia <[email-masked]>
Subject: Re: ***New WHO Interim Guidance on COVID-19 Clinical Management***

გამარჯობა, ქალბატონო თამარ,

აკაკის ველაპარაკე დღეს და  გაირკვა, რომ გაგზავნილი ჰქონიათ  კლინიკური ჯგუფის სხვა წევრებისთვის გადასახედად ახალი ვერსია და გამომიგზავნის მეც;

ჩვენ შევადარებთ, რა თქმა უნდა რა არის განსხვავებული და ახალი.

პატივისცემით,

ალისა წულაძე

Best regards,

Alisa Tsuladze

ჯანმრთელობის დაცვის პოლიტიკის სამმართველო

პოლიტიკის დეპარტამენტი

საქართველოს ოკუპირებული ტერიტორიებიდან დევნილთა,

შრომის, ჯანმრთელობისა და სოციალური დაცვის სამინისტრო

+995-32-2-51-00-26  ext 1125

Health Policy Division

Policy Department

Ministry of Internally Displaced persons from

Occupied Territories, Labor, Health and Social Affairs of Georgia

From: Tamar Gabunia
Sent: Monday, May 25, 2020 8:36 AM
To: Ekaterine Adamia
Cc: Anzor tchavtchavadze; Alisa Tsuladze
Subject: RE: ***New WHO Interim Guidance on COVID-19 Clinical Management***

ალისა

გთხოვ გადახედო ჯანმოს ახალ გაიდლაინს, ამოკრიბო განსახვავებული დებულებები და დავიწყოთ მუშაობა ჩვენი გაიდლაინის განახლებაზე. ‘

პატივისცემით,

თამარ გაბუნია

მინისტრის პირველი მოადგილე

Sincerely,

Tamar Gabunia, MD, MPH

First Deputy Minister

From: MAMULASHVILI, Nino [mailto:[email-masked]]
Sent: 22 May, 2020 19:15
To: Ekaterine Adamia <[email-masked]>
Cc: Tamar Gabunia <[email-masked]>; DOMENTE, Silviu <[email-masked]>; [email-masked]' <[email-masked]>; Anzor tchavtchavadze <[email-masked]>; Alisa Tsuladze <[email-masked]>
Subject: FW: ***New WHO Interim Guidance on COVID-19 Clinical Management***
Importance: High

Dear Eka,

Hopefully you have received a new WHO Interim Guidance on COVID-19 Clinical Management.

Kind regards,

Nino

From: LYDON, Patrick
Sent: Thursday, May 21, 2020 22:49
To: solidaritytrials <[email-masked]>
Cc: SWAMINATHAN, Soumya <[email-masked]>; HENAO RESTREPO, Ana Maria <[email-masked]>; PREZIOSI, Marie-pierre <[email-masked]>; SATHIYAMOORTHY, Vaseeharan <[email-masked]>; DARA, Masoud <[email-masked]>; OKEIBUNOR, Joseph Chukwudi <[email-masked]>; Reveiz, Dr. Ludovic (WDC) <[email-masked]>; Maria Consuelo <[email-masked]>; KODAMA, Chiori <[email-masked]>; AZIM, Tasnim <[email-masked]>; ESCALANTE, Socorro <[email-masked]>
Subject: ***New WHO Interim Guidance on COVID-19 Clinical Management***
Importance: High

Dear Solidarity Trial P.Is and esteemed colleagues,

We are pleased to be sharing with you the new WHO ‘interim’ guidance on COVID-19 clinical management (attached). This is a key documents in our collective objective to: (1) Slow and stop transmission of the virus; (2) Provide optimized care for all patients; and (3) Minimize the impact of the epidemic on health systems, social services and economic activity.

This guidance is intended for clinicians involved in the care of patients with suspected or confirmed COVID-19. As all of you copied are involved in the Solidarity Trial, we wanted to make sure you get this document and we encourage you to share this broadly within your networks. Please note that it is not meant to replace clinical judgment or specialist consultation, but rather to strengthen frontline clinical management based on the latest WHO guidance.

Furthermore, we wanted to thank you for all your hard work, dedication and time with enrolling patients in Solidarity Trial. To date, 17 countries have started Solidarity Trial in 320 hospitals around the world and where 885 clinicians including yourselves are involved. Patient enrollment has surpassed 3,000 on May 18th – 8 weeks since the launch of the initiative on March 18 by the Director General of the WHO (Dr. Tedros). By the end of May, we expect another 10-12 countries to start enrolling patients with at least one country representing each WHO region. This is tremendous progress and we owe it to you. You should all be proud to be part of this global mega-trial to help research into an effective COVID-19 treatment and your efforts are not going unnoticed.

Of course, the battle against this pandemic is far from over and time is not on our side. The faster we can go, the quicker we can identify solutions. The international community is counting on your help to implement and accelerate all possible efforts for Solidarity Trial and to enroll as many patients as possible.

All the very best and keep safe.

Patrick

(on behalf of Dr Soumya (WHO Chief Scientist); the co-leads of Solidarity Trial (Dr Ana Maria, Dr Marie-Pierre and Dr Vasee); and our Regional and Country Office Focal points that have done an incredible job helping)

___________________________________________________________________________
Patrick Lydon

Research & Development Blueprint Unit  – WHO Health Emergencies Preparedness & Response

World Health Organization | 20 Avenue Appia | CH-1211 Geneva 27 Switzerland | Office: M1156
*: [email-masked] |(:office +41.22.791.4238 |(:mobile +41.79.475.5550 |(:skype: patricklydon

Promote health, keep the world safe, and serve the vulnerable